Jinyu Deferred Long Term Liab from 2010 to 2025
| 600201 Stock | 7.57 0.06 0.80% |
Deferred Long Term Liabilities | First Reported 2018-06-30 | Previous Quarter 334.5 M | Current Value 343 M | Quarterly Volatility 74.1 M |
Check Jinyu Bio-Technology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jinyu Bio-Technology's main balance sheet or income statement drivers, such as Interest Expense of 58.3 K, Selling General Administrative of 230.1 M or Total Revenue of 1 B, as well as many indicators such as . Jinyu financial statements analysis is a perfect complement when working with Jinyu Bio-Technology Valuation or Volatility modules.
Jinyu | Deferred Long Term Liab |
Currently Active Assets on Macroaxis
Other Information on Investing in Jinyu Stock
Jinyu Bio-Technology financial ratios help investors to determine whether Jinyu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jinyu with respect to the benefits of owning Jinyu Bio-Technology security.